OCC 1.32% 38.5¢ orthocell limited

FDA significance, page-429

  1. 765 Posts.
    lightbulb Created with Sketch. 124
    The problem i see is you can't sell what you don't have, they are in the process of having so no point marketing it just yet. Once approvals and partnerships are in place we can go out marketing with all guns blazing. You can make a bucket load of money accumulating shares in companies at this stage of development because there is a big risk they well never reach launch. This is where it becomes your call whether you think they will or wont.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.